GI
PACB icon

GAMMA Investing’s Pacific Biosciences PACB Stock Holding History

GAMMA Investing’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.32K Sell
2,572
-393
-13% -$571 ﹤0.01% 3530
2026
Q1 		$3.91K Sell
2,965
-8,568
-74% -$15.3K ﹤0.01% 3455
2025
Q4 		$21.6K Buy
+11,533
New +$22.2K ﹤0.01% 2568
2025
Q1 		– Sell
-305
Closed -$558 – 3864
2024
Q4 		$558 Buy
+305
New +$595 ﹤0.01% 3557
2024
Q2 		– Sell
-103
Closed -$386 – 3496
2024
Q1 		$386 Sell
103
-870
-89% -$5.09K ﹤0.01% 3142
2023
Q4 		$6.33K Buy
+973
New +$7.96K ﹤0.01% 2125

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GAMMA Investing's PACB Position: Q2 2026 in Review

GAMMA Investing reduced its Pacific Biosciences (PACB) stake by 13% in Q2 2026, selling an estimated $571 and leaving 2,572 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #3530.

GAMMA Investing first reported a position in PACB in Q4 2023 and has held it in 6 quarters since. The position peaked at $21.6K in Q4 2025. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • GAMMA Investing held 2,572 shares of Pacific Biosciences worth $4.32K as of Q2 2026.
  • GAMMA Investing sold 393 Pacific Biosciences shares in Q2 2026, an estimated $571.
  • Pacific Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3530 holding.
  • GAMMA Investing first reported a position in Pacific Biosciences in Q4 2023 and has held it in 6 quarters since.
  • GAMMA Investing's Pacific Biosciences position peaked at $21.6K in Q4 2025.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.